Experts from academia and industry discuss how to create a new, more effective translational neuroscience drawing on novel technology and recent discoveries.
Today, translational neuroscience faces significant challenges. Available therapies to treat brain and nervous system disorders are extremely limited and dated, and further development has effectively ceased. Disinvestment by the private sector occurred just as promising new technologies in genomics, stem cell biology, and neuroscience emerged to offer new possibilities. In this volume, experts from both academia and industry discuss how novel technologies and reworked translation concepts can create a more effective translational neuroscience.
The contributors consider such topics as using genomics and neuroscience for better diagnostics and biomarker identification; new approaches to disease based on stem cell technology and more careful use of animal models; and greater attention to human biology and what it will take to make new therapies available for clinical use. They conclude with a conceptual roadmap for an effective and credible translational neuroscience—one informed by a disease-focused knowledge base and clinical experience.
Contributors
Tobias M. Böckers, Thomas Bourgeron, Karl Broich, Nils Brose, Bruce N. Cuthbert, Ilka Diester, Gül Dölen, Guoping Feng, Richard Frackowiak, Raquel E. Gur, Stephan Heckers, Franz Hefti, David M. Holtzman, Steven E. Hyman, Nancy Ip, Cynthia Joyce, Tobias Kaiser, Edward H. Koo, Walter J. Koroshetz, Katja S. Kroker, Robert C. Malenka, Isabelle Mansuy, Eliezer, Masliah, Yuan Mei, Andreas Meyer-Lindenberg, Lennart Mucke, Pierluigi Nicotera, Karoly Nikolich, Michael J. Owen, Menelas N. Pangalos, Alvaro Pascual-Leone, Joel S. Perlmutter, Trevor W. Robbins, Lee L. Rubin, Akira Sawa, Mareike Schnaars, Bernd Sommer, Maria Grazia Spillantini, Laura Spinney, Matthew W. State, Marius Wernig
Le informazioni nella sezione "Riassunto" possono far riferimento a edizioni diverse di questo titolo.
Karoly Nikolich is Consulting Professor in the Department of Psychiatry at Stanford University Medical School as well as Founder of Circuit Therapeutics and Chairman of Alkahest, two biotechnology companies that grew out of research done at Stanford. Steven E. Hyman is Harvard University Distinguished Professor of Stem Cell and Regenerative Biology and Director of the Stanley Center for Psychiatric Research at the Broad Institute of MIT and Harvard.
Le informazioni nella sezione "Su questo libro" possono far riferimento a edizioni diverse di questo titolo.
Spese di spedizione:
EUR 11,65
Da: Regno Unito a: U.S.A.
Descrizione libro Condizione: New. In. Codice articolo ria9780262029865_new
Descrizione libro Hardcover. Condizione: new. New. Codice articolo Wizard0262029863
Descrizione libro Hardcover. Condizione: new. New. Fast Shipping and good customer service. Codice articolo Holz_New_0262029863
Descrizione libro Hardcover. Condizione: new. Prompt service guaranteed. Codice articolo Clean0262029863
Descrizione libro Condizione: new. Codice articolo FrontCover0262029863
Descrizione libro Hardcover. Condizione: new. New Copy. Customer Service Guaranteed. Codice articolo think0262029863
Descrizione libro Hardcover. Condizione: New. Brand New!. Codice articolo VIB0262029863
Descrizione libro Hardcover. Condizione: Brand New. 1st edition. 303 pages. 10.75x7.75x1.25 inches. In Stock. Codice articolo 0262029863
Descrizione libro Condizione: New. Buy with confidence! Book is in new, never-used condition. Codice articolo bk0262029863xvz189zvxnew
Descrizione libro Condizione: New. New! This book is in the same immaculate condition as when it was published. Codice articolo 353-0262029863-new